New search | Conferencedetail
Print view

Striving towards the elimination of HCV infection, Berlin 2018

EASL The Home of Hepatology
Conference themes
Globally, morbidity and mortality due to HCV infection continues to rise. However, the availability of simple and tolerable DAA therapies for HCV infection with cure rates >90% is one of the greatest medical advances in decades. This has brought considerable optimism to people working in HCV. The WHO has set an ambitious goal to eliminate HCV as a major public health threat by 2030.
Professional congress organizer (PCO)
evvnt Platform / evvnt


Speakers: Prof. Francesco Negro, Dr. Alessio Aghemo, Prof. Jason Grebely

Enquiries and Registration:

Mr. EASL The Home of Hepatology
General Medicine
Congress fees
EASL Member Early fee: EUR 300 EASL Member: EUR 450 Non Member Early fee: EUR 450 Non Member : EUR 550
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichisches Rotes KreuzÖsterreichische Akademie der ÄrzteAMREF - African Medical and Research FoundationnewTreeAGEM - Arbeitsgemeinschaft Ethnomedizin e. V.European Health Forum GasteinHilfswerk AustriaCharité International Academy


Give us your professional opinion

Start survey

Start survey